Standout Papers
Citation Impact
Citing Papers
In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance
2006
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis
2006
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
Pharmacodynamics of Caspofungin in a Murine Model of Systemic Candidiasis: Importance of Persistence of Caspofungin in Tissues to Understanding Drug Activity
2005
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Rapid Host Defense against Aspergillus fumigatus Involves Alveolar Macrophages with a Predominance of Alternatively Activated Phenotype
2011
Health and related indicators 2021
2022
Barriers to Accessing Antiretroviral Therapy in Kisesa, Tanzania: A Qualitative Study of Early Rural Referrals to the National Program
2006
Care during labor and birth for the prevention of intrapartum-related neonatal deaths: a systematic review and Delphi estimation of mortality effect
2011
A Preliminary Randomized Controlled Trial of a Nurse-Delivered Medication Adherence Intervention Among HIV-Positive Outpatients Initiating Antiretroviral Therapy in Beijing, China
2010
The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol
2009
No health without mental health
2007 Standout
In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods
1999
Quality of Life of Patients With Advanced HIV/AIDS: Measuring the Impact of Both AIDS-Defining Events and Non-AIDS Serious Adverse Events
2009
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response
2009
Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001
2003
Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey
2009 Standout
Vulvovaginal candidosis
2007 Standout
In Vitro Activity of the New Echinocandin Antifungal, MK-0991, against Common and Uncommon Clinical Isolates of Candida Species
1999
Impact of Community-Based Behaviour-Change Management on Perceived Neonatal Morbidity: A Cluster-Randomized Controlled Trial in Shivgarh, Uttar Pradesh, India
2011
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial
2010
Resuscitation and Obstetrical Care to Reduce Intrapartum-Related Neonatal Deaths: A MANDATE Study
2015
Early childhood development coming of age: science through the life course
2016 Standout
Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries
2015
Stillbirths: how can health systems deliver for mothers and babies?
2011
Anidulafungin versus Fluconazole for Invasive Candidiasis
2007
Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda
2007
Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals
2016 Standout
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Glucan synthase inhibitors as antifungal agents
2001
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy
2010
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Every Newborn: health-systems bottlenecks and strategies to accelerate scale-up in countries
2014
Effect of Facilitation of Local Maternal-and-Newborn Stakeholder Groups on Neonatal Mortality: Cluster-Randomized Controlled Trial
2013
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Reproductive, maternal, newborn, and child health in Pakistan: challenges and opportunities
2013
The burden of non-communicable diseases in South Africa
2009 Standout
Home Visits to Improve Adherence to Highly Active Antiretroviral Therapy
2006
Impact of Malaria at the End of Pregnancy on Infant Mortality and Morbidity
2011
Acute Infectious Diarrhea
2003
Determinants of patient adherence: a review of systematic reviews
2013
Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
2003
Fungal ß(1,3)-D-glucan synthesis
2001
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Cohort Profile: Hlabisa HIV Treatment and Care Programme
2010
Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies
2011
Epidemiology of invasive candidiasis
2010
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy
2003
Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries
2009
Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders
2011 Standout
Short- and Long-Term Efficacy of Modified Directly Observed Antiretroviral Treatment in Mombasa, Kenya: A Randomized Trial
2008
Malaria
2013 Standout
Anisakidosis: Perils of the Deep
2010 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Morbidity and Mortality According to Latest CD4+ Cell Count among HIV Positive Individuals in South Africa Who Enrolled in Project Phidisa
2015
Echinocandin antifungal drugs
2003 Standout
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Echinocandin resistance
2014
Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa
2009
Midwifery and quality care: findings from a new evidence-informed framework for maternal and newborn care
2014 Standout
Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial
2016
Effectiveness of strategies incorporating training and support of traditional birth attendants on perinatal and maternal mortality: meta-analysis
2011
Challenges for Scaling up ART in a Resource-Limited Setting: A Retrospective Study in Kibera, Kenya
2009
Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia
2009
Sickle-cell disease
2010 Standout
Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis
2013
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
The contribution of melanin to microbial pathogenesis
2003
Stillbirths: what difference can we make and at what cost?
2011
Arborcandins A, B, C, D, E and F, Novel 1,3-.BETA.-Glucan Synthase Inhibitors. Production and Biological Activity.
2000
A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS?
2007
Helicobacter pyloriInfection
2002 Standout
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations
2006
Population Causes and Consequences of Leading Chronic Diseases: A Comparative Analysis of Prevailing Explanations
2008
Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods
2002
Peer Support and Pager Messaging to Promote Antiretroviral Modifying Therapy in Seattle: A Randomized Controlled Trial
2009
Reproductive, maternal, newborn, and child health: key messages from Disease Control Priorities 3rd Edition
2016
Requirements for high impact diagnostics in the developing world
2006 StandoutNature
Protective and pathogenic functions of macrophage subsets
2011 Standout
Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis
2006
A Randomized Controlled Trial Comparing the Effects of Counseling and Alarm Device on HAART Adherence and Virologic Outcomes
2011
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Patient-Level Moderators of the Efficacy of Peer Support and Pager Reminder Interventions to Promote Antiretroviral Adherence
2011
The health and health system of South Africa: historical roots of current public health challenges
2009 Standout
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
2014 Standout
Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin
2005
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Longitudinal Antiretroviral Adherence in HIV+ Ugandan Parents and Their Children Initiating HAART in the MTCT-Plus Family Treatment Model: Role of Depression in Declining Adherence Over Time
2009
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America
2006
Can Treatment Adherence Be Improved by Using Rubin's Four Tendencies Framework to Understand a Patient's Response to Expectations
2017 Standout
The spleen and sickle cell disease: the sick(led) spleen
2014
Correlation between Antifungal Susceptibilities of Coccidioides immitis In Vitro and Antifungal Treatment with Caspofungin in a Mouse Model
2001
Assessing Resistance to the Echinocandin Antifungal Drug Caspofungin in Candida albicans by Profiling Mutations in FKS1
2006
Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts
1998
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis
2019 StandoutNobel
Invasive Fungal Pathogens: Current Epidemiological Trends
2006
Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome
2005
Copper Active Sites in Biology
2014 Standout
Antifungal Susceptibility ofCandidaBiofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins
2002
Caspofungin
2003
Comparison of the Echinocandin Caspofungin with Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in a Murine Model
2000
Stillbirths: Where? When? Why? How to make the data count?
2011 Standout
Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia
2002
Laboratory diagnosis of invasive aspergillosis
2005
Traditional birth attendant training for improving health behaviours and pregnancy outcomes
2012
Molecular Evolution of Antifungal Drug Resistance
2017
Candida albicans and Candida glabrata Clinical Isolates Exhibiting Reduced Echinocandin Susceptibility
2006
In Vitro Activity of Caspofungin (MK-0991) against Candida albicans Clinical Isolates Displaying Different Mechanisms of Azole Resistance
2002
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Efficacy of MK-991 (L-743,872), a Semisynthetic Pneumocandin, in Murine Models of Pneumocystis carinii
1998
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
The Antifungal Echinocandin Caspofungin Acetate Kills Growing Cells of Aspergillus fumigatus In Vitro
2002
Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: Evidence of Concentration‐Dependent Activity
2004
Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatus
2003
Single- and Multiple-Dose Pharmacokinetics of Caspofungin in Healthy Men
2002
Riddle of Biofilm Resistance
2001 Standout
Invasive Candidiasis
2015 Standout
In Vivo Pharmacodynamics of HMR 3270, a Glucan Synthase Inhibitor, in a Murine Candidiasis Model
2003
Efficacy of the Echinocandin Caspofungin against Disseminated Aspergillosis and Candidiasis in Cyclophosphamide-Induced Immunosuppressed Mice
2000
Postantifungal Effects of Echinocandin, Azole, and Polyene Antifungal Agents against Candida albicans and Cryptococcus neoformans
2000
Further Standardization of Broth Microdilution Methodology for In Vitro Susceptibility Testing of Caspofungin against Candida Species by Use of an International Collection of More than 3,000 Clinical Isolates
2004
Economic evaluation of neonatal care packages in a cluster-randomized controlled trial in Sylhet, Bangladesh
2013
Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis
2002
Overexpression ofCandida albicans CDR1,CDR2, orMDR1Does Not Produce Significant Changes in Echinocandin Susceptibility
2006
What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review
2006
Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates of Aspergillus fumigatus
2013
Newborn Mortality and Fresh Stillbirth Rates in Tanzania After Helping Babies Breathe Training
2013
Emergence of DiverseHelicobacterSpecies in the Pathogenesis of Gastric and Enterohepatic Diseases
2001
Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Disseminated Candidiasis and Aspergillosis
2000
Interventions for enhancing medication adherence
2014 Standout
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies
1996
A millennium update on pediatric diarrheal illness in the developing world
2005
Aspergillus fumigatusand Aspergillosis
1999 Standout
Influence of Human Sera on the In Vitro Activity of the Echinocandin Caspofungin (MK-0991) against Aspergillus fumigatus
2000
Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors
1997
In vitrogrowth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistantCandidaisolates: influence of assay conditions
1997
Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes
2015 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health
2019
In Vitro Interaction of Caspofungin Acetate with Voriconazole against Clinical Isolates of Aspergillus spp
2002
Adolescence: a foundation for future health
2012 Standout
In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi
2000
Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases
2002
Treatment of murine Candida krusei or Candida glabrata infection with L-743,872
1997
Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries.
2013
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates
1996
In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp
2002
Global Surveillance of In Vitro Activity of Micafungin against Candida : a Comparison with Caspofungin by CLSI-Recommended Methods
2006
Born Too Soon: Care for the preterm baby
2013
Treatment of murine disseminated candidiasis with L-743,872
1997
Efficacies of Fluconazole, Caspofungin, and Amphotericin B inCandida glabrata-Infected p47phox−/−Knockout Mice
2002
Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Pulmonary Aspergillosis
2000
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis
2015
Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro
1997
Works of Christopher Gill being referenced
Using Electronic Drug Monitor Feedback to Improve Adherence to Antiretroviral Therapy Among HIV-Positive Patients in China
2009
Covid-19 deaths in Africa: prospective systematic postmortem surveillance study
2021
Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents
2010
Effect of training traditional birth attendants on neonatal mortality (Lufwanyama Neonatal Survival Project): randomised controlled study
2011
Training Zambian traditional birth attendants to reduce neonatal mortality in the Lufwanyama Neonatal Survival Project (LUNESP)
2012
Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review
2007
Relationship of HIV Viral Loads, CD4 Counts, and HAART Use to Health-Related Quality of Life
2002
Diagnostic Accuracy of Stool Assays for Inflammatory Bacterial Gastroenteritis in Developed and Resource-Poor Countries
2003
Evaluation of Experimental Therapeutics in a New Mouse Model ofHelicobacter felisUtilizing 16S rRNA Polymerase Chain Reaction for Detection
1997
Importance of Dose Timing to Achieving Undetectable Viral Loads
2009
Costs and Cost-Effectiveness of Training Traditional Birth Attendants to Reduce Neonatal Mortality in the Lufwanyama Neonatal Survival Study (LUNESP)
2012
Two‐Dose versus Monthly Intermittent Preventive Treatment of Malaria with Sulfadoxine‐Pyrimethamine in HIV‐Seropositive Pregnant Zambian Women
2007
No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa
2005
Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: a systematic review, meta-analysis and Delphi estimation of mortality effect
2011
Bottlenecks, barriers, and solutions: results from multicountry consultations focused on reduction of childhood pneumonia and diarrhoea deaths
2013
Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators
2006
Quantitative PCR Assay To Measure Aspergillus fumigatus Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate
2001
Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates
2005
Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
1997
Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study
2008
Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease
2013
An Uninvited Dinner Guest
2005
A sensitive and specific PCR method to detect Helicobacter felis in a conventional mouse model
1996
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
1997
In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373
1995
Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
1995